These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34061325)

  • 1. Melatonin and neuroblastoma: a novel therapeutic approach.
    Pourhanifeh MH; Kamali M; Mehrzadi S; Hosseinzadeh A
    Mol Biol Rep; 2021 May; 48(5):4659-4665. PubMed ID: 34061325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of melatonin in prevention and treatment of lung cancer.
    Ngai ZN; Chok KC; Ng KY; Koh RY; Chye SM
    Horm Mol Biol Clin Investig; 2022 Dec; 43(4):485-503. PubMed ID: 35728260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes.
    Pizarro JG; Yeste-Velasco M; Esparza JL; Verdaguer E; Pallàs M; Camins A; Folch J
    J Pineal Res; 2008 Aug; 45(1):8-16. PubMed ID: 18284548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.
    Lissoni P; Malugani F; Brivio F; Piazza A; Vintimilla C; Giani L; Tancini G
    Neuro Endocrinol Lett; 2003; 24(3-4):259-62. PubMed ID: 14523367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
    Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
    J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and Biological Functions of Melatonin in Endometrial Cancer.
    Dana PM; Sadoughi F; Mobini M; Shafabakhsh R; Chaichian S; Moazzami B; Chamani M; Asemi Z
    Curr Drug Targets; 2020; 21(5):519-526. PubMed ID: 31560286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pineal hormone melatonin in complex pharmacotherapy of brain and somatic disorders].
    Arushanian EB
    Eksp Klin Farmakol; 2011; 74(9):39-45. PubMed ID: 22164447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin and Cancer Hallmarks.
    Talib WH
    Molecules; 2018 Feb; 23(3):. PubMed ID: 29495398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and pancreatic cancer: Current knowledge and future perspectives.
    Tamtaji OR; Mirhosseini N; Reiter RJ; Behnamfar M; Asemi Z
    J Cell Physiol; 2019 May; 234(5):5372-5378. PubMed ID: 30229898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mTOR signaling pathway in pediatric neuroblastoma.
    Mei H; Wang Y; Lin Z; Tong Q
    Pediatr Hematol Oncol; 2013 Oct; 30(7):605-15. PubMed ID: 23697980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor dynamics and neuroendocrine signalling in the mouse pineal gland: a comparative analysis of melatonin-deficient C57BL mice and melatonin-proficient C3H mice.
    von Gall C; Lewy A; Schomerus C; Vivien-Roels B; Pevét P; Korf HW; Stehle JH
    Eur J Neurosci; 2000 Mar; 12(3):964-72. PubMed ID: 10762326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence.
    Moradian F; Pourhanifeh MH; Mehrzadi S; Karimi-Behnagh A; Hosseinzadeh A
    Fundam Clin Pharmacol; 2022 Oct; 36(5):777-789. PubMed ID: 35384044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current understanding of pineal gland structure and function in headache.
    Peres MF; Valença MM; Amaral FG; Cipolla-Neto J
    Cephalalgia; 2019 Nov; 39(13):1700-1709. PubMed ID: 31370669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy.
    Lee WJ; Chen LC; Lin JH; Cheng TC; Kuo CC; Wu CH; Chang HW; Tu SH; Ho YS
    Cancer Med; 2019 Aug; 8(10):4821-4835. PubMed ID: 31274246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Targeting of
    Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
    Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemosensitivity assay.
    Bartsch H; Buchberger A; Franz H; Bartsch C; Maidonis I; Mecke D; Bayer E
    Life Sci; 2000 Nov; 67(24):2953-60. PubMed ID: 11133007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limitation of oxidative stress as the main factor of the universal protective properties of melatonin].
    Arushanian ÉB
    Eksp Klin Farmakol; 2012; 75(5):44-9. PubMed ID: 22834130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
    Olivera GG; Urtasun A; Sendra L; Aliño SF; Yáñez Y; Segura V; Gargallo P; Berlanga P; Castel V; Cañete A; Herrero MJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.